Goldman Sachs
JAGX icon

Goldman Sachs’s Jaguar Health JAGX Stock Holding History

Goldman Sachs’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7
Closed -$59.5K – 6154
2024
Q3 		$59.5K Buy
+7
New +$76.1K ﹤0.01% 5618
2022
Q3 		– Hold
0
– -$3K – 6408
2022
Q2 		– Hold
0
– – – 6374
2022
Q1 		– Hold
0
– – – 6310
2021
Q4 		– Hold
0
– – – 6358
2018
Q4 		– Hold
0
– -$10K – 5461
2018
Q3 		– Hold
0
– – – 5467
2017
Q4 		– Hold
0
– -$22K – 6509
2017
Q3 		– Hold
0
– – – 6415
2016
Q2 		– Hold
0
– -$25K – 7136
2016
Q1 		– Hold
0
– – – 6682
2015
Q4 		– Hold
0
– -$33K – 7251
2015
Q3 		– Hold
0
– – – 6922
2015
Q2 		– Hold
0
– – – 6857

Other funds holding JAGX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Goldman Sachs's JAGX Position: Q4 2024 in Review

Goldman Sachs sold out of Jaguar Health (JAGX) in Q4 2024, closing a stake of 7 shares — an estimated $59.5K sold.

Goldman Sachs first reported a position in JAGX in Q3 2024 and held it in 1 quarter. The position peaked at $59.5K in Q3 2024. 7 funds tracked by Wall St. Rank hold JAGX as of Q4 2024.

  • Goldman Sachs reported no remaining Jaguar Health position as of Q4 2024 after selling out during the quarter.
  • Goldman Sachs sold 7 Jaguar Health shares in Q4 2024, an estimated $59.5K.
  • Goldman Sachs first reported a position in Jaguar Health in Q3 2024 and held it in 1 quarter.
  • Goldman Sachs's Jaguar Health position peaked at $59.5K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Jaguar Health as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.